Bluejay Diagnostics (BJDX) Cash from Investing Activities (2021 - 2026)

Bluejay Diagnostics has reported Cash from Investing Activities for 5 years, with the latest figure at -$15314.0 in Q1 2026.

• Quarterly Cash from Investing Activities changed N/A year-over-year to -$15314.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$286664.0 (changed N/A YoY) and the FY2025 annual result came in at -$173735.0, up 43.37% from the prior year.
• Cash from Investing Activities retreated to -$15314.0 in Q1 2026 per BJDX's latest filing, from -$1125.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$227.0 in Q3 2024 and troughed at -$791464.0 in Q3 2022.
• A 4-year average of -$171194.8 and a median of -$87894.0 in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities tumbled 18392.15% in 2022, then jumped 99.7% in 2024.
• Over 4 years, Cash from Investing Activities stood at -$238207.0 in 2022, then soared by 63.1% to -$87894.0 in 2023, then jumped by 98.72% to -$1125.0 in 2024, then slumped by 1261.24% to -$15314.0 in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$15314.0, -$1125.0, and -$227.0 for Q1 2026, Q4 2024, and Q3 2024 respectively.